Cite
HARVARD Citation
Hunter, D. et al. (n.d.). Joint safety and neurologic events with subcutaneous tanezumab or oral nonsteroidal anti-inflammatory drugs in subgroups of patients with osteoarthritis from an 80-week phase 3 study. Osteoarthritis and cartilage. pp. S246-S247. [Online].